Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Grant/Award of 10,200 TECX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Tectonic Therapeutic, Inc. (TECX) | Grant/Award | 10,200 | n/a |
| Jan 6, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,600 | n/a |
| Jun 11, 2025 | Tectonic Therapeutic, Inc. (TECX) | Grant/Award | 10,200 | n/a |
| Apr 11, 2025 | Tectonic Therapeutic, Inc. (TECX) | Purchase | 2,861 | $41.8K |
| Apr 11, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Purchase | 7,342 | $69.2K |
| Apr 9, 2025 | Tectonic Therapeutic, Inc. (TECX) | Purchase | 87,500 | $1.50M |
| Mar 20, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Purchase | 14,740 | $212.6K |
| Feb 7, 2025 | Tectonic Therapeutic, Inc. (TECX) | Purchase | 129,294 | $7.00M |
| Jan 15, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Purchase | 7,962 | $134.2K |
| Jan 6, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,600 | n/a |